Erkut Borazanci, MD
HonorHealth Research Institute · Scottsdale Healthcare Hospitals DBA HonorHealth
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Erkut Borazanci, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:43 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05229588 · Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair MutationsHonorHealth Research Institute · completed · Gastrointestinal Malignancies · principal investigator
- Ph2NCT05216120 · Pemigatinib in Subjects With Adenosquamous Carcinoma of the PancreasHonorHealth Research Institute · withdrawn · Pancreas Cancer · principal investigator
- Ph2NCT05068752 · Phase II Trial of Vemurafenib and Sorafenib in Pancreatic CancerHonorHealth Research Institute · completed · Pancreas Cancer · principal investigator
- Ph2NCT04669197 · Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas CancerHonorHealth Research Institute · completed · Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma · principal investigator
- Ph1/Ph2NCT04203641 · L-DOS47 Plus Doxorubicin in Advanced Pancreatic CancerHelix BioPharma Corporation · terminated · Pancreas Cancer · principal investigator
- Ph2NCT03415854 · Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)HonorHealth Research Institute · completed · Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma · principal investigator
- Ph2NCT03138720 · Pre-operative Treatment for Patients With Untreated Pancreatic CancerHonorHealth Research Institute · completed · Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma · principal investigator
- N/ANCT02790944 · Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic CancerAmbry Genetics · completed · Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph2NCT02754726 · Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal AdenocarcinomaHonorHealth Research Institute · completed · Untreated Metastatic Pancreatic Ductal Adenocarcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.